Edition:
United States

Analyst Research

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : GlobalData
$300.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$300.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Zealand Pharma A/S maintains FY 2014 financial guidance


Friday, 22 Aug 2014 02:30am EDT 

Zealand Pharma A/S:Says expects FY 2014 revenue from milestone payments of 133 million Danish crowns.Says net operating expenses in FY 2014 are expected at a range of 195 million Danish crowns.